Magnolia Medical Technologies, Inc. v. Kurin, Inc., No. 24-2001 (Fed. Cir. Mar. 6, 2026)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Magnolia Medical Technologies, Inc. (“Magnolia”) filed suit in the United States District Court for the District of Delaware, asserting that Kurin, Inc. (“Kurin”) infringed claims 1 and 24 of its U.S. Patent 10,039,483 (“the ’483 pa- tent”) and claims 1, 21, and 48 of its U.S. Patent 9,855,001 (“the ’001 patent”). Based on the district court’s construc- tion that the claims of the ’001 patent contained a means - plus-function term, the parties entered into a stipulation of no infringement as to that patent. See Magnolia Med. Techs., Inc. v.